Clinical Trial Detail

NCT ID NCT01798901
Title AR-42 and Decitabine in Treating Patients With Acute Myeloid Leukemia
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Alison Walker
Indications

acute myeloid leukemia

Therapies

AR-42 + Decitabine

Age Groups: adult child

No variant requirements are available.